Cargando…
S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
S2.2 HISTOPLASMOSIS AND TALAROMYCOSIS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: : Talaromycosis is an infection caused by the thermally dimorphic fungus Talaromyces marneffei (T. marneffei). It is endemic in tropical countries of Asia and Southeast Asia and has recently been recognized far beyond t...
Autor principal: | Cao, Cunwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554595/ http://dx.doi.org/10.1093/mmy/myac072.S2.2c |
Ejemplares similares
-
P403 Metagenomic sequencing as an effective diagnostic tool for Talaromycosis in HIV-negative patients: A retrospective study
por: Liang, Tianwei, et al.
Publicado: (2022) -
Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021) -
Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022) -
S2.2a African histoplasmosis
por: Oladele, Rita
Publicado: (2022) -
Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)